(Q44053298)

29 November 2017

title

Topiramate and metabolic acidosis in infants and toddlers (English)

1 reference

29 November 2017

1 reference

1 reference

Heike Philippi

1

1 reference

29 November 2017

Rainer Boor

series ordinal

2

1 reference

29 November 2017

Bernd Reitter

series ordinal

3

1 reference

29 November 2017

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

43

1 reference

29 November 2017

issue

7

1 reference

29 November 2017

page(s)

744-747

1 reference

A pilot study of topiramate in the treatment of infantile spasms

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.37201.X

Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.37201.X

Topiramate for intractable childhood epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.37201.X

Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.37201.X

Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.37201.X

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.37201.X

Topiramate and metabolic acidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.37201.X

10.1046/J.1528-1157.2002.37201.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference